The cHCC-ICC groups had significantly higher transaminase levels at the time of diagnosis (AST: 206 vs. 46, p = 0.012; ALT: 165.5 vs. 48, p = 0.013). This evidence concerns the gene GPT and intrahepatic cholangiocarcinoma.